NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NLH - CA66980G1090 - Common Stock
0.29 CAD
-0.02 (-6.45%)
Overall NLH gets a fundamental rating of 4 out of 10. We evaluated NLH against 15 industry peers in the Health Care Providers & Services industry. NLH has only an average score on both its financial health and profitability. NLH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- NLH had positive earnings in the past year.
- NLH had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
- In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
- NLH has a Return On Assets of 3.18%. This is in the better half of the industry: NLH outperforms 80.00% of its industry peers.
- With a decent Return On Equity value of 4.00%, NLH is doing good in the industry, outperforming 80.00% of the companies in the same industry.
- NLH's Return On Invested Capital of 4.16% is fine compared to the rest of the industry. NLH outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROIC | 4.16% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.50%, NLH is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
- In the last couple of years the Profit Margin of NLH has declined.
- The Operating Margin of NLH (3.56%) is better than 66.67% of its industry peers.
- NLH has a Gross Margin (39.51%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
- NLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for NLH has been increased compared to 1 year ago.
- NLH has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for NLH is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.62 indicates that NLH is not in any danger for bankruptcy at the moment.
- NLH has a better Altman-Z score (3.62) than 93.33% of its industry peers.
- NLH has a debt to FCF ratio of 1.89. This is a very positive value and a sign of high solvency as it would only need 1.89 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.89, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- NLH has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.04, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 3.62 |
ROIC/WACC0.52
WACC7.96%
2.3 Liquidity
- A Current Ratio of 0.93 indicates that NLH may have some problems paying its short term obligations.
- NLH's Current ratio of 0.93 is amongst the best of the industry. NLH outperforms 86.67% of its industry peers.
- A Quick Ratio of 0.93 indicates that NLH may have some problems paying its short term obligations.
- NLH has a Quick ratio of 0.93. This is amongst the best in the industry. NLH outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 260.00% over the past year.
- The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
- The Revenue has grown by 16.47% in the past year. This is quite good.
- The Revenue has been growing by 8.16% on average over the past years. This is quite good.
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 29.00 indicates a quite expensive valuation of NLH.
- Based on the Price/Earnings ratio, NLH is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of NLH to the average of the S&P500 Index (27.30), we can say NLH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NLH is valued cheaper than 86.67% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.5 | ||
| EV/EBITDA | 10.67 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NOVA LEAP HEALTH CORP / NLH.CA FAQ
What is the ChartMill fundamental rating of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 5 / 10.
What is the valuation of NOVA LEAP HEALTH CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NOVA LEAP HEALTH CORP (NLH.CA) is 29 and the Price/Book (PB) ratio is 0.98.